The New Hampshire House of Representatives has approved a bipartisan bill to legalize the regulated use of psilocybin for medical purposes.
After unanimously passing the House Health, Human Services and Elderly Affairs Committee late last month, the full chamber advanced it in voice vote on the consent calendar on Thursday. It now goes to the House Finance Committee before a final floor vote that could move it to the Senate.
The legislation from Rep. Buzz Scherr (D) would create a regulatory pathway for patients with certain conditions to access the psychedelic for therapeutic use through a program overseen by the state Department of Health and Human Services (DHHS).
Rep. Yury Polozov (R) said in a committee report that the bill would provide needed access to psilocybin “under medical supervision for conditions such as treatment-resistant depression, post-traumatic stress disorder, substance use disorders, and other qualifying diagnoses determined by an advisory board and the department.”
“This legislation offers a balanced, medically-supervised approach to therapeutic psilocybin use,” he said. “It addresses unmet needs for individuals with severe, treatment-resistant conditions by providing access in a controlled environment, grounded in emerging scientific evidence and harm reduction principles.”
Here are the key provisions of HB 1809:
Read full article on Marijuana Moment
